This paper describes the systematic development process of a paper patient decision aid for ovarian cancer risk management in pre‐menopausal BRCA1/2 mutation carriers, in close collaboration with BRCA1/2 mutation carriers and their health‐care professionals. Here, BRCA1 is linked to ovarian carcinoma.